Investigation of HLA-DPA1 genotypes as predictors of inflammatory bowel disease in the German, South African, and South Korean populations

International Journal of Colorectal Disease

Volumn 17, Issue 4, 2002, Pages 238-244

  Lantermann, Annette ^a   Hampe, Jochen ^a   Kim, Won H ^b   Winter, Trevor A ^c   Kidd, Mark ^c   Nagy, Marion ^d   Fölsch, Ulrich R ^a   Schreiber, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Crohn's disease; HLA DP; Human leukocyte antigen; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

AMINO ACID; HLA DP ANTIGEN; HLA DP1 ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DNA POLYMORPHISM; ENTERITIS; EXON; FAMILY STUDY; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; NONPARAMETRIC TEST; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH AFRICA; SOUTH KOREA; STATISTICAL ANALYSIS; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; EPITOPES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HAPLOTYPES; HLA-DP ANTIGENS; HUMANS; INFLAMMATORY BOWEL DISEASES; KOREA; LINKAGE (GENETICS); POLYMORPHISM, GENETIC; SOUTH AFRICA;

EID: 0036938262     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-001-0382-3     Document Type: Article

References (53)

1. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3:7 and 12. Nat Genet 14:199-202
2. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379:821-823
3. Hampe J, Schreiber S, Shaw SH, Lau KF, Bridget S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Buckler A, Hall J, Stokkers P, van Deventer SJ, Nurnberg P, Mirza MM, Lee JC, Lennard-Jones JE, Mathew CG, Curran ME (1999) A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 64:808-816
4. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, Pickles MR, Qin L, Fu Y, Mann JS, Kirschner BS, Jabs EW, Weber J, Hanauer SB, Bayless TM, Brant SR (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 95:7502-7507
5. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
6. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
7. Hampe J, Cuthbert A, Croucher PJ, Mirza M, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, Van Deventer SJ, Forbes A, Nikolaus S, Lennard-Jones J, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew C (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357:1925-1928
8. Soravia C, Berk T, Cohen Z (2000) Genetic testing and surgical decision making in hereditary colorectal cancer. Int J Colorectal Dis 15:21-28
9. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP (1996) Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347:1212-1217
10. Yang H, Plevy SE, Taylor K, Tyan D, Fischel-Ghodsian N, McElree C, Targan SR, Rotter JI (1999) Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut 44:519-526
11. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridget S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S (1999) Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 65:1641-1655
12. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, Green T, Brettin TS, Stone V, Bull SB, Bitton A, Williams CN, Greenberg GR, Cohen Z, Lander ES, Hudson TJ, Siminovitch KA (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66:1863-1870
13. Gleeson MH, Walker JS, Wentzel J, Chapman JA, Harris R (1972) Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut 13:438-440
14. Purrmann J, Korsten S, Bertrams J, Miller B, Lapsien B, Munch H, Reis HE, Strohmeyer G (1985) [HLA haplotype study in familial Crohn disease]. Z Gastroenterol 23:432-437
15. Fujita K, Naito S, Okabe N, Yao T (1984) Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese. J Clin Lab Immunol 14:99-102
16. Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pena AS (1996) Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 103:391-396
17. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H (1996) Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 110:1053-1060
18. Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ (1999) HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 45:395-401
19. Bouma G, Crusius JB, Garcia-Gonzalez MA, Meijer BU, Hellemans HP, Hakvoort RJ, Schreuder GM, Kostense PJ, Meuwissen SG, Pena AS (1999) Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol 115:294-300
20. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP (1997) Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112:1845-1853
21. Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky DK, Pillai S (1998) Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut 43:210-215
22. Trachtenberg EA, Yang H, Hayes E, Vinson M, Lin C, Targan SR, Tyan D, Erlich H, Rotter JI (2000) HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations. Hum Immunol 61:326-333
23. Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T (1999) HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 53:350-358
24. Stokkers PC, de Heer K, Leegwater AC, Reitsma PH, Tytgat GN, van Deventer SJ (1999) Inflammatory bowel disease and the genes for the natural resistance-associated macrophage protein-1 and the interferon-gamma receptor 1. Int J Colorectal Dis 14:13-17
25. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A (1995) HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 109:1462-1467
26. Gorski J, Rollini P, Long E, Mach B (1984) Molecular organization of the HLA-SB region of the human major histocompatibility complex and evidence for two SB beta-chain genes. Proc Natl Acad Sci USA 81:3934-3938
27. Servenius B, Gustafsson K, Widmark E, Emmoth E, Andersson G, Larhammar D, Rask L, Peterson PA (1984) Molecular map of the human HLA-SB (HLA-DP) region and sequence of an SB alpha (DP alpha) pseudogene. EMBO J 3:3209-3214
28. Lawrance SK, Das HK, Pan J, Weissman SM (1985) The genomic organisation and nucleotide sequence of the HLA-SB (DP) alpha gene. Nucleic Acids Res 13:7515-7528
29. Mayer L, Eisenhardt D, Salomon P, Bauer W, Plous R, Piccinini L (1991) Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology 100:3-12
30. Momburg F, Koretz K, Von Herbay A, Moller P (1988) Nonimmune human cells can express MHC class II antigens in the absence of invariant chainan immunohistological study on normal and chronically inflamed small intestine. Clin Exp Immunol 72:367-372
31. Horie Y, Chiba M, Iizuka M, Masamune O (1990) Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine. Gastroenterol Jpn 25:575-584
32. Koretz K, Momburg F, Otto HF, Moller P (1987) Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. Am J Pathol 129:493-502
33. Sturgess RP, Hooper LB, Spencer J, Hung CH, Nelufer JM, Ciclitira PJ (1992) Effects of interferon-gamma and tumour necrosis factor-alpha on epithelial HLA class-II expression on jejunal mucosal biopsy specimens cultured in vitro. Scand J Gastroenterol 27:907-911
34. Salomon P, Pizzimenti A, Panja A, Reisman A, Mayer L (1991) The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium. Autoimmunity 9:141-149
35. Pallone F, Fais S, Capobianchi MR (1988) HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli: Clin Exp Immunol 74:75-79
36. Gaston JS, Goodall JC, Young JL, Young SP (1997) Effect of polymorphism of the HLA-DPA1 chain on presentation of antigenic peptides. Hum Immunol 54:40-47
37. Hampe J, Hermann B, Bridger S, MacPherson AJ, Mathew CG, Schreiber S (1998) The interferon-gamma gene as a positional and functional candidate gene for inflammatory bowel disease. Int J Colorectal Dis 13:260-263
38. Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Stokkers P, Van Deventer SJ, Mirza M, Raedler A, Kruis W, Meckler U, Theuer D, Herrmann T, Gionchetti P, Lee J, Mathew C, Lennard-Jones J (1998) Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes. 12 and 16. Gastroenterology 115:1066-1071
39. Wright JP, Froggatt J, O'Keefe EA, Ackerman S, Watermeyer S, Louw J, Adams G, Girdwood AH, Burns DG, Marks IN (1986) The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J 70:10-15
40. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6
41. Podolsky DK (1991) Inflammatory bowel disease (1). N Engl J Med 325:928-937
42. Nagy M, Roewer L (1992) Die PCR-Analyse. Ann Univ Sarav Med Suppl 9:145-152
43. Hall J, Nanthakumar E (1997) Automated fluorescent genotyping. In: Boyle AL (ed) Current protocols in human genetics, vol 2. Wiley, New York, pp 2.8.1-2.8.19
44. Clayton D (1999) A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65:1170-1177
45. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and non-parametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
46. Terwiliger J, Ott J (1994) Handbook of human genetic linkage. Johns Hopkins University Press, Baltimore
47. Anonymous (1996) 12th International Histocompatibility Conference. Genetic diversity of HLA: functional and medical implications. Paris, France, June 9-12. Abstracts. Hum Immunol 47:1-184
48. Perdriger A, Guggenbuhl P, Chales G, Le Dantec P, Yaouanq J, Genetet B, Pawlotsky Y, Semana G (1996) The role of HLA-DR-DR and HLA-DR-DP interactions in genetic susceptibility to rheumatoid arthritis. Hum Immunol 46:42-48
49. Hitman GA (1989) The major histocompatibility complex and insulin dependent (type 1) diabetes. Autoimmunity 4:119-130
50. Begovich AB, Moonsamy PV, Mack SJ, Barcellos LF, Steiner LL, Grams S, Suraj-Baker V, Hollenbach J, Trachtenberg E, Louie L, Zimmermann P, Hill AVS, Stoneking M, Sasazuki T, Konenkov VI, Sartakova ML, Titanji VPK, Rickards O, Klitz W (2001) Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens 57:424-439
51. Schmehl K, Florian S, Jacobasch G, Salomon A, Korber J (2000) Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa. Int J Colorectal Dis 15:39-48
52. Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP (2000) Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118:274-278
53. Hugot JP, Zouali H, Lesage S, Thomas G (1999) Etiology of the inflammatory bowel diseases. Int J Colorectal Dis 14:2-9